Washington | 12°C (overcast clouds)
India's Drug Watchdog Flags Substandard Medicines and Issues Urgent Warning on Kidney Risks from Painkillers and Antibiotics

CDSCO Uncovers Over 220 Substandard Drugs, Urges Caution on Painkiller & Antibiotic Misuse Due to Kidney Risks

India's Central Drugs Standard Control Organisation (CDSCO) has identified 220 "not of standard quality" drugs and one spurious sample. Simultaneously, it issued a critical advisory against the indiscriminate use of painkillers and antibiotics, citing severe risks to kidney health and increasing antimicrobial resistance.

It seems our nation's health vigilant, the Central Drugs Standard Control Organisation (CDSCO), has been rather busy. Just recently, they dropped a significant double-whammy: revealing a considerable number of substandard medicines making their way around, and simultaneously, issuing a very serious warning about how we're using – or rather, misusing – common painkillers and antibiotics.

Their rigorous surveillance in August brought to light some concerning figures. A staggering 220 drug samples were identified as 'not of standard quality' (NSQ), and even more troubling, one particular sample was outright declared 'spurious.' This spurious find, a truly worrying discovery, originated from Delhi and is currently under intense investigation. Now, it’s crucial to understand what 'not of standard quality' truly means; the CDSCO clarifies this typically pertains to a specific batch that failed tests, not necessarily every single variant of that medicine out there. Still, it’s a stark reminder that vigilance is paramount.

But the CDSCO's focus didn't stop there. In a separate, yet equally critical move, they published an advisory on September 22nd, 2026, aimed squarely at a widespread public health concern: the indiscriminate use of certain everyday medications.

This particular warning zeroed in on two culprits we often take for granted: painkillers, especially Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and antibiotics. The message was unequivocal: casual, unprescribed, or excessive use of these drugs can lead to grave health consequences. We're talking about serious renal complications – significant kidney risks – and a worrying acceleration of antimicrobial resistance. The latter, as many experts constantly remind us, is a silent pandemic in itself, rendering once-effective treatments useless. It’s a sobering thought, really.

So, what does all this mean for us? Well, it’s a powerful twofold reminder. Firstly, our drug regulators are actively working to ensure the medicines we consume are safe and effective, even if some slip through. And secondly, and perhaps more importantly, we, as individuals, bear a responsibility. Before reaching for that painkiller or demanding an antibiotic, let's pause. A quick chat with a doctor or pharmacist isn't just a good idea; it’s essential for safeguarding our long-term health, particularly our kidneys, and for preserving the efficacy of vital medicines for generations to come. Health, after all, isn't something to gamble with.

Comments 0
Please login to post a comment. Login
No approved comments yet.

Editorial note: Nishadil may use AI assistance for news drafting and formatting. Readers can report issues from this page, and material corrections are reviewed under our editorial standards.